Tirzepatide, the only FDA-approved dual GIP/GLP-1 receptor agonist, is a peptide with potent and imbalanced co-agonism at both GIPR and GLP-1R
43 The focus should be on finding a starting point that feels achievable and building from there
If we dont get action soon, real robust legislative action to put a stop to low reimbursements to pharmacies by the PBMs, he said, we are right at the tipping point where there is going to be an access problem for patients getting their medicine.
January 23, 2026 | health Creatine and Protein: the Most Recommended Supplement Stack Seeking improved athletic or workout performance
Karlsson, T., Hadizadeh, F., Rask-Andersen, M., Johansson, & Ek, W
The UPenn team used large language models to translate informal descriptions into standardized medical vocabulary, enabling large-scale pattern recognition that would be impossible manually